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Rotavirus (RV)-encoded nonstructural protein 1 (NSP1), the product of
gene segment 5, effectively antagonizes host interferon (IFN) signaling via multiple
mechanisms. Recent studies with the newly established RV reverse genetics system
indicate that NSP1 is not essential for the replication of the simian RV SA11 strain in
cell culture. However, the role of NSP1 in RV infection in vivo remains poorly characterized due to the limited replication of heterologous simian RVs in the suckling mouse
model. Here, we used an optimized reverse genetics system and successfully recovered
recombinant murine RVs with or without NSP1 expression. While the NSP1-null virus
replicated comparably with the parental murine RV in IFN-deﬁcient and IFN-competent
cell lines in vitro, it was highly attenuated in 5-day-old wild-type suckling pups in both
the 129sv and C57BL/6 backgrounds. In the absence of NSP1 expression, murine RV
had signiﬁcantly reduced replication in the ileum, systemic spread to mesenteric lymph
nodes, fecal shedding, diarrhea occurrence, and transmission to uninoculated littermates. The defective replication of the NSP1-null RV in small intestinal tissues occurred
as early as 1 day postinfection. Of interest, the replication and pathogenesis defects of
NSP1-null RV were only minimally rescued in Stat1 knockout pups, suggesting that
NSP1 facilitates RV replication in an IFN-independent manner. Our ﬁndings highlight a
pivotal function of NSP1 during homologous RV infections in vivo and identify NSP1 as
an ideal viral protein for targeted attenuation for future vaccine development.
IMPORTANCE Rotavirus remains one of the most important causes of severe diarrhea
and dehydration in young children worldwide. Although NSP1 is dispensable for rotavirus replication in cell culture, its exact role in virus infection in vivo remains unclear. In
this study, we demonstrate, for the ﬁrst time in a pathologically valid homologous
small animal model, that in the context of a fully replication-competent, pathogenic,
and transmissible murine rotavirus, loss of NSP1 expression substantially attenuated virus replication in the gastrointestinal tract, diarrheal disease, and virus transmission.
Notably, the NSP1-deﬁcient murine rotavirus also replicated poorly in mice lacking host
interferon or inﬂammasome signaling. Our data provide the ﬁrst piece of evidence that
NSP1 is essential for murine rotavirus replication in vivo, making it an attractive target
for developing improved next-generation rotavirus vaccines better suited for socioeconomically disadvantaged and immunocompromised individuals.
KEYWORDS NSP1, double-stranded RNA virus, enteric viruses, innate immunity,
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espite a dramatic reduction of rotavirus (RV)-associated morbidity and mortality
following the introduction of multiple safe and effective RV vaccines, group A RVs
remain a major cause of life-threatening gastroenteritis among young children from
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RESULTS
A recombinant NSP1-deﬁcient murine RV can be successfully rescued via an
optimized RG system. To determine the role of NSP1 in viral replication in vivo, we utilized the recombinant D6/2 murine-like RV backbone with 2 gene segments (1 and 10)
derived from the simian RV SA11 strain and the other 9 gene segments (including
NSP1) from the murine RV D6/2 strain (designated here rD6/2-2g) (22). In order to generate an NSP1-deﬁcient rD6/2-2g virus (rD6/2-2g-NSP1-null), we introduced two premature stop codons in gene segment 5 by replacing AAG and TGC at the nucleotide
positions 43 to 45 and 52 to 55 with TAG and TGA, respectively, via site-directed mutagenesis (Fig. 1A). With these manipulations, the protein product of gene 5 from the
rD6/2-2g-NSP1-null infection is limited to the ﬁrst 4 amino acids. Using the optimized
RG system, we succeeded in recovering a replication-competent rD6/2-2g-NSP1-null.
We next extracted the viral RNA from sucrose cushion-puriﬁed RVs and performed
polyacrylamide gel electrophoresis (PAGE) to analyze the viral genomic doublestranded RNA (dsRNA) segments. The genomic dsRNA migration patterns were identical between rD6/2-2g and rD6/2-2g-NSP1-null viruses, with the genes 1 and 10 from
SA11 and the remaining 9 genes from D6/2 (Fig. 1B). We also validated the NSP1-null
virus by a unique enzymatic digestion site (HinfI) introduced by the second stop
codon. In comparison, cDNA ampliﬁed from gene segment 5 of rD6/2-2g was resistant
to HinfI digestion (Fig. 1C). Lastly, we examined IRF3 degradation as a functional readout of murine RV NSP1 expression. To that end, we performed immunoblotting analysis to examine the cell lysates of MA104 cells infected by rD6/2-2g and rD6/2-2g-NSP1null. With similar protein levels of RV VP6, indicating comparable replication between
November/December 2021 Volume 12 Issue 6 e03208-21

mbio.asm.org 2

Downloaded from https://journals.asm.org/journal/mbio on 11 April 2022 by 128.252.154.28.

1 month to 5 years old (1, 2). RV infections still result in approximately 128,500 to
215,000 deaths annually worldwide (3, 4). The RV vaccine option is also limited for
immunocompromised children due to the risk of persistent shedding and diarrhea (5).
Thus, there remains an urgent need to develop more effective vaccines, especially for
immunosuppressed individuals.
Although RV infections in mammals occur frequently (6), RV isolates from one host
species generally replicate less efﬁciently in heterologous species. Several RV-encoded
factors, including VP3, VP4, NSP1, NSP2, and NSP3, have been implicated in contributing to this host range restriction phenotype (7). Among these viral proteins, NSP1 has
been identiﬁed as an interferon (IFN) antagonist with several distinct mechanisms that
enhances virus replication (8–12). NSP1 from many animal RV strains binds to and promotes the proteasomal degradation of interferon regulatory factor 3 (IRF3) (9, 13).
NSP1 also recognizes and degrades IRF5, IRF7, and IRF9 (14, 15). NSP1 from several
human and porcine RV strains binds to the host cullin-3 E3 ligase complex (16) and
induces b -transduction repeat-containing protein ( b -TrCP) degradation (17). In addition, NSP1 can directly target signal transducer and activator of transcription 1 (STAT1)
phosphorylation and/or translocation into the nucleus to further block the IFN ampliﬁcation pathway (10, 18). Taken together, all of these studies have established NSP1 as a
potent inhibitor of the host IFN responses to facilitate RV replication.
With the development of a new plasmid-based RV reverse genetics (RG) system,
several groups successfully rescued recombinant simian RVs (SA11 strain), including
one in which NSP1 is almost completely replaced by a NanoLuc luciferase reporter
except for the ﬁrst 37 amino acids at the N terminus (19, 20). The replication of this
recombinant SA11 is only modestly lower than the parental SA11 strain in MA104 cells,
suggesting that NSP1 is dispensable for RV infection in vitro. However, since heterologous RVs replicate and spread inefﬁciently in mice (21), the role of NSP1 in RV infection under physiologically relevant conditions cannot be studied using this system. To
overcome this hurdle, we recently constructed and recovered a fully replication-competent, infectious, and virulent recombinant murine RV using an optimized RG system
(22). In this study, we take advantage of this modiﬁed RG system and further generate
a new NSP1-deﬁcient murine RV to directly address the signiﬁcance and functional
relevance of the NSP1 protein in intestinal replication and pathogenesis in vivo.

®

FIG 1 Generation of a recombinant NSP1-deﬁcient murine RV using the optimized reverse genetics system. (A) Schematics of
the plasmids used to rescue rD6/2-2g (pT7-NSP1) and NSP1-deﬁcient rD6/2-2g-NSP1-null (pT7-NSP1-null) viruses. To generate
the rD6/2-2g-NSP1-null virus, AAG and TGC at the nucleotide positions 43 to 45 and 52 to 55 were replaced with two stop
codons, TAG and TGA, which are indicated by the black arrowheads. UTR, untranslated region; ORF, open reading frame; aa,
amino acids. (B) RNA was extracted from sucrose gradient-concentrated indicated RV strains, separated on a 4 to 15%
polyacrylamide gel, and stained by ethidium bromide. Genes 1 and 10 from the SA11 strain are marked by red asterisks. (C)
The stop codon introduced at nucleotide positions 52 to 55 creates a unique HinfI digestion site. The NSP1 59-end PCR
products were digested by HinfI at 37°C for 1 h and separated by a 2% agarose gel. (D) MA104 cells were infected by
parental rD6/2-2g or rD6/2-2g-NSP1-null at an MOI of 3 for 6 h. The infected cells were lysed by RIPA buffer, and the protein
levels of IRF3, VP6, and GAPDH in the cell lysates were analyzed by immunoblotting using indicated antibodies.

rD6/2-2g and rD6/2-2g-NSP1-null, the protein levels of IRF3 were undetectable in rD6/
2-2g-infected MA104 cells whereas IRF3 was not degraded by rD6/2-2g-NSP1-null
infection (Fig. 1D). Based on these results, we demonstrate that the rD6/2-2g-NSP1-null
virus was successfully rescued and did not express the NSP1 protein.
The replication of a recombinant NSP1-deﬁcient murine RV is comparable to
the parental murine RV in multiple cell lines. To determine whether the loss of NSP1
protein negatively impacts virus replication in cell culture, we performed a multistep
growth curve for rD6/2-2g and rD6/2-2g-NSP1-null in MA104 cells at a multiplicity of
infection (MOI) of 0.01. Both focus-forming unit (FFU) and quantitative reverse transcription-PCR (RT-qPCR) assays did not reveal signiﬁcant differences between rD6/2-2g
and rD6/2-2g-NSP1-null over the time course (Fig. 2A and B). The plaque sizes of rD6/
2-2g-NSP1-null (diameter, 2.07 6 0.53 mm) were signiﬁcantly smaller than those of
rD6/2-2g (diameter, 4.53 6 0.99 mm) in MA104 cells (Fig. 2C). We also validated the
genetic stability of rD6/2-2g-NSP1-null by serially passaging the virus 5 times in MA104
cells and conﬁrming the presence of two stop codons in gene segment 5 (Fig. 2D).
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FIG 2 Replication kinetics of rD6/2-2g and rD6/2-2g-NSP1-null in MA104 cells. (A) MA104 cells were infected with rD6/2-2g or rD6/2-2g-NSP1-null at an
MOI of 0.01 (FFU/cell) for 0, 12, 24, 36, and 48 h. Infected cells were harvested by freezing and thawing 3 times. The titers of the propagated viruses at
different time points were determined by an FFU assay. The data displayed are the mean 6 SD for three different assays. (B) MA104 cells were infected as
described above for 0, 8, and 24 h. RNA was extracted from infected cells, and RT-qPCR was used to measure RV NSP5 transcript levels in infected cells.
The data shown are the mean 6 SD for three different assays. (C) Plaque assays were performed for rD6/2-2g or rD6/2-2g-NSP1-null in MA104 cells at an
MOI of 0.01, and individual plaque formation was recorded and measured at 5 dpi by a bright-ﬁeld microscope. The data shown are the mean 6 SD for
two different assays. (D) Indicated recombinant murine RVs were serially passaged 5 times in MA104 cells. The NSP1 fragments were ampliﬁed from the
viruses and analyzed by Sanger sequencing. ***, P , 0.001; n.s., not signiﬁcant (unpaired Student’s t test).

These results are consistent with the previous report that an intact NSP1 is not required
for simian RV SA11 strain infection in MA104 cells (19, 20). To test whether the lack of
NSP1 results in a minor replication defect that was not apparent in cell culture, we carried out competition experiments in MA104 cells coinfected with the same titers of
rD6/2-2g and rD6/2-2g-NSP1-null viruses. At either low MOI (0.01) or high MOI (3), rD6/
2-2g did not outgrow rD6/2-2g-NSP1-null RV at 8 and 24 h postinfection (hpi), suggesting that the replication ability of rD6/2-2g-NSP1-null was comparable to rD6/2-2g (see
Fig. S1 in the supplemental material).
Since NSP1 dampens the host IFN responses, which are defective in MA104 cells,
we next tested whether the replication of rD6/2-2g-NSP1-null is restricted in IFN-competent cell lines. We examined the growth kinetics of rD6/2-2g and rD6/2-2g-NSP1-null
in two different cell types: HEK293 and HAP1 cells, which are a human embryonic ﬁbroblastic cell line and a human myeloid leukemia cell line, respectively. Both cell types
are capable of mounting robust type I and III IFN responses to RV infection (23).
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However, the rD6/2-2g-NSP1-null mutant still replicated comparably to rD6/2-2g in
these IFN-competent cell lines (Fig. 3A and B), suggesting that NSP1 is dispensable for
murine RV replication in an IFN competency-independent manner.
Loss of NSP1 severely attenuates murine RV replication in 129sv suckling mice.
To compare the replication, pathogenesis, and spread of rD6/2-2g and rD6/2-2g-NSP1null in an in vivo environment, we orally inoculated 5-day-old wild-type 129sv suckling
mice with 1.5  103 FFU of rD6/2-2g or rD6/2-2g-NSP1-null and monitored the diarrheal development from day 1 to 12 postinfection. While the diarrhea occurrence from
the rD6/2-2g-infected group was consistently higher than 70% for the ﬁrst 10 days,
rD6/2-2g-NSP1-null caused minimal to no diarrhea in infected animals for the ﬁrst
2 days (Fig. 4A). Starting from 3 days postinfection (dpi), rD6/2-2g-NSP1-null started to
approximate the parental virus, with their curves eventually trending in a similar fashion (Fig. 4A). We also quantiﬁed the shedding of infectious RVs in the feces of mouse
pups by an FFU assay. Consistent with the defects in causing diarrhea, fecal shedding
of rD6/2-2g-NSP1-null in infected mice could not be detected at 1 and 2 dpi, whereas
we observed high RV titers from the rD6/2-2g infection (Fig. 4B). The two virus shedding curves looked similar from 3 to 5 dpi, before the RV shedding in rD6/2-2g-NSP1null-infected pups waned again compared to that of the rD6/2-2g group (Fig. 4B).
Furthermore, we also evaluated the ability of these two viruses to transmit to uninfected littermates, an important trait for viruses that spread fecal-orally. We found that
virtually all the noninoculated littermates of the rD6/2-2g-infected pups developed diarrhea at 6 dpi (Fig. 4C). In comparison, the maximal percentage of diarrhea among
mock-infected pups in the rD6/2-2g-NSP1-null cage reached 40% and lasted only
1 day (Fig. 4C). Collectively, these results suggest that NSP1 is necessary for optimal RV
infection, disease, and spread in vivo.
To directly investigate whether NSP1 contributes to RV intestinal replication, we collected all three small intestinal segments (i.e., duodenum, jejunum, and ileum) from
rD6/2-2g- and rD6/2-2g-NSP1-null-infected pups at 2 dpi and measured viral loads by
RT-qPCR. The number of rD6/2-2g genome copies in the ileum was signiﬁcantly (about
3 logs) higher than that of rD6/2-2g-NSP1-null, despite no major differences in the duodenum and jejunum (Fig. 5A). We also found that the viral loads of rD6/2-2g in mesenteric lymph nodes (MLNs) were higher than those of rD6/2-2g-NSP1-null, whereas
no difference were observed in the blood, bile ducts, or liver (Fig. 5B to E).
We next performed an in vivo time course experiment to further characterize the
attenuated intestinal replication of rD6/2-2g-NSP1-null. With similar input virus titers
throughout the small intestine at 1 hpi, the replication levels of rD6/2-2g and rD6/22g-NSP1-null were comparable at 8 hpi (approximately one replication cycle) as measured by RT-qPCR (Fig. 6A and B). In contrast, rD6/2-2g genome copies in the jejunum
were signiﬁcantly (more than 2 logs) higher than those of rD6/2-2g-NSP1-null at 24 hpi
November/December 2021 Volume 12 Issue 6 e03208-21
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FIG 3 Growth curves of rD6/2-2g and rD6/2-2g-NSP1-null in IFN-competent cells. HEK293 (A) and HAP1 (B) cells
were infected by rD6/2-2g and rD6/2-2g-NSP1-null at an MOI of 0.01 for 0, 8, 24, and 48 h. The expression level of
NSP5 was quantiﬁed by RT-qPCR. The data shown are the mean 6 SD for three individual assays. **, P , 0.01;
n.s., not signiﬁcant (unpaired Student’s t test).
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(Fig. 6C). Although not statistically signiﬁcant, the viral load of rD6/2-2g in the ileum was
also more than 10-fold higher than that of rD6/2-2g-NSP1-null, suggesting that NSP1 was
required for murine RV infection to successfully propagate in vivo by 24 hpi.
Revertant NSP1 mutations rescued NSP1-deﬁcient murine RV replication in
mice. Notably, we noticed that 4 out of 14 mice from the rD6/2-2g-NSP1-null-infected
group shed large amounts of infectious viruses in the feces at 3 dpi (Fig. 4B). This was
reproducibly observed in two independent sets of experiments (6 out of 7 at 4 dpi in
one experiment and 4 out of 7 at 3 dpi in the other experiment) (Fig. S2). To account
for this enhanced replication, we ampliﬁed the 59 end of gene 5 (17 to 466 nucleotides)
directly from the stool samples collected from mice that had detectable RV shedding
from 1 to 4 dpi and performed Sanger sequencing. While the rD6/2-2g-NSP1-null RV
stock used for inoculation carried the mutations (Fig. S3A), NSP1 fragments ampliﬁed
from the feces of the rD6/2-2g-NSP1-null-infected mice were indistinguishable from
those from rD6/2-2g infection (Fig. S3B), indicating that RV in the fecal specimens readily reverted to the wild-type sequences. While we could not detect any RV shedding
from rD6/2-2g-NSP1-null-infected mice at 1 or 2 dpi, 75% of mice that shed infectious
RVs at 3 dpi had complete NSP1 reversion mutations and 25% had incomplete reversion (Fig. S3B). Six out of 14 mice infected with rD6/2-2g-NSP1-null shed virus at 4 dpi,
and all 6 animals had wild-type NSP1 sequences (Fig. S3B). These data are consistent
with our observation that the rD6/2-2g-NSP1-null-infected mice unexpectedly developed diarrhea starting from 3 dpi and further emphasize an indispensable role that
NSP1 protein plays during virus replication in vivo.
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FIG 4 Characterization of diarrhea, fecal shedding, and transmission of rD6/2-2g and rD6/2-2g-NSP1-null in wild-type
129sv mice. (A) Five-day-old 129sv mice were orally inoculated with 1.5  103 FFU of rD6/2-2g and rD6/2-2g-NSP1-null.
Diarrheal development was recorded from days 1 to 12 postinfection. “n” indicates the number of mice used in each
group. (B) Fecal shedding of the infectious RVs was monitored by an FFU assay and normalized by the weight of feces.
Virus shedding within the same group on each day is shown as mean 6 SEM. (C) To evaluate the transmission ability of
rD6/2-2g, 2 pups were orally infected with 1.5  103 FFU of rD6/2-2g, and 5 uninfected suckling littermates were
cohoused with the inoculated pups in the same cage. For rD6/2-2g-NSP1-null, 2 pups in one cage and 2 in another cage
were orally infected with the rD6/2-2g-NSP1-null virus described above and cohoused with 6 and 4 uninoculated pups,
respectively. Diarrhea was evaluated until 12 dpi as described above. *, P , 0.05; **, P , 0.01; ***, P , 0.001; n.s., not
signiﬁcant (two-way ANOVA).
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The blunted replication and pathogenesis of the recombinant NSP1-deﬁcient
murine RV are only partially recovered in the Stat1 KO mice. Since NSP1 functions
as a highly potent IFN antagonist in vitro, we reasoned that rD6/2-2g-NSP1-null may be
attenuated in wild-type 129sv mice due to the lack of IFN-inhibitory capacity. To test
this hypothesis, we orally infected 5-day-old Stat1 knockout (KO) 129sv suckling pups,
unable to respond to type I, II, and III IFNs, with 1.5  103 FFU of rD6/2-2g or rD6/2-2gNSP1-null. For both viruses, the overall diarrheal development patterns in infected
Stat1 KO 129sv mice resembled those in wild-type mice (Fig. 7A). However, compared
to rD6/2-2g-infected animals that developed 57% and 100% diarrhea at 1 and 2 dpi,
respectively, there was little to no diarrhea from rD6/2-2g-NSP1-null-inoculated animals (Fig. 7A). We also evaluated the fecal RV shedding in the infected mice by an FFU
assay. Even in the absence of IFN signaling, at 1 and 2 dpi, RV shedding of rD6/2-2g
remained .3 logs higher than that from the rD6/2-2g-NSP1-null infection (Fig. 7B),
suggesting that NSP1 may facilitate RV replication in an IFN-independent manner.
Consistent with the diarrhea and fecal shedding results, we found that for all the
small intestinal tissues examined, rD6/2-2g-NSP1-null was still severely attenuated
compared to rD6/2-2g in Stat1 KO mice at 2 dpi (Fig. 8A). The viral loads of rD6/2-2g in
the ileum were approximately 7,000-fold higher than those of rD6/2-2g-NSP1-nullinfected mice (Fig. 8A). Furthermore, rD6/2-2g also had signiﬁcantly more spread to
systemic organs including the blood, MLNs, bile duct, and liver than rD6/2-2g-NSP1null (Fig. 8B to E). Collectively, these data indicate that even in a host devoid of IFN signaling, the replication of a murine RV without NSP1 expression remains highly attenuated in vivo.
November/December 2021 Volume 12 Issue 6 e03208-21
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FIG 5 Viral loads of rD6/2-2g and rD6/2-2g-NSP1-null in the small intestines and indicated systemic sites in
wild-type 129sv mice. (A) Five-day-old wild-type 129sv pups were orally infected with 1.5  103 FFU of rD6/22g and rD6/2-2g-NSP1-null. RNA was extracted from duodenum, jejunum, and ileum collected at 2 dpi, and RTqPCR was used to detect RV NSP5 mRNA levels. (B to E) Same as panel A except that blood, MLNs, bile duct,
and liver were collected instead. ***, P , 0.001; n.s., not signiﬁcant (Mann-Whitney U test for panel A and
unpaired Student’s t test for panels B to E).

Hou et al.
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Further supporting an IFN-independent role of NSP1 is the fact that rD6/2-2g-NSP1null also reverted to the wild-type sequences in Stat1 KO mice. We surveyed over 30 fecal
samples from the rD6/2-2g-NSP1-null-infected mice. Out of the 8 mice that shed infectious RVs at 1 dpi, 25% of the mice had complete NSP1 revertant mutations and 75% of
the mice had incomplete reversion (Fig. S3C). At 4 dpi, 8 out of the 10 mice that had substantial fecal shedding had viruses with wild-type NSP1 sequences (Fig. S3C). Therefore,
all NSP1-deﬁcient viruses reached 100% reversion in Stat1 KO 129sv mice by 4 dpi, the
same as that in the wild-type 129sv mice.
The attenuated replication of the recombinant NSP1-deﬁcient murine RV is not
rescued in the Asc knockout mice. Since inﬂammasome signaling inhibits RV infection

FIG 7 Characterization of diarrhea and fecal shedding of rD6/2-2g and rD6/2-2g-NSP1-null in Stat1 KO 129sv mice. (A) Fiveday-old Stat1 KO 129sv mice were orally inoculated with 1.5  103 FFU of rD6/2-2g and rD6/2-2g-NSP1-null. The diarrhea rate
was monitored from days 1 to 12 postinfection. (B) Viral shedding in stool samples was detected by an FFU assay and
normalized by the feces weight. Virus shedding within one group on each day is shown as mean 6 SEM. *, P , 0.05; n.s., not
signiﬁcant (two-way ANOVA).
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FIG 6 Viral loads of rD6/2-2g and rD6/2-2g-NSP1-null in the small intestines at different time points in wild-type
129sv mice. (A) Five-day-old wild-type 129sv pups were orally infected with 1.5  103 FFU of rD6/2-2g and rD6/2-2gNSP1-null. RNA was extracted from duodenum, jejunum, and ileum collected at 1 h postinoculation, and RT-qPCR was
used to detect RV NSP5 mRNA levels. (B and C) Same as panel A except that duodenum, jejunum, and ileum were
collected at 8 and 24 h postinoculation instead. *, P , 0.05; n.s., not signiﬁcant (Mann-Whitney U test).
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®

and RV viral loads are signiﬁcantly enhanced in the small intestines of Asc KO mice
(24), which lack a key inﬂammasome adaptor protein, we next tested whether NSP1
acts to block inﬂammasome signaling. We orally infected 5-day-old wild-type C57BL/6
and Asc KO suckling pups with rD6/2-2g or rD6/2-2g-NSP1-null with 1.5  103 FFU and
harvested the small intestines at 24 hpi.
Historically, we have noticed that C57BL/6 mice develop less severe diarrhea than
129sv pups of the same age (25). Consistent with these ﬁndings, we observed lower
levels of rD6/2-2g replication in the small intestines of C57BL/6 pups compared to
129sv pups (Fig. S4A). Importantly, the viral loads of rD6/2-2g in the jejunum were signiﬁcantly higher than those of rD6/2-2g-NSP1-null-inoculated wild-type C57BL/6 mice
(Fig. S4A), suggesting that a key function of NSP1 is required, irrespective of the mouse
genetic background. Further, in Asc KO C57BL/6 mice, the viral loads of rD6/2-2g in the
jejunum were still signiﬁcantly higher than those of rD6/2-2g-NSP1-null-inoculated
mice (Fig. S4B). These results indicate that the attenuated intestinal replication ability
of NSP1-deﬁcient RV may not be linked to host inﬂammasome signaling.
The attenuated replication of the recombinant NSP1-deﬁcient simian RV SA11
is not rescued in Stat1 KO mice. To further corroborate the unexpected ﬁnding that
NSP1 is required for RV replication in Stat1 KO mice, we turned to the heterologous
simian RV SA11 strain that leads to low but detectable fecal shedding when the mice
are inoculated at a high dose (1  107 PFU) (21). We successfully rescued an NSP1-deﬁcient SA11 strain (rSA11-NSP1-null), which was given to 5-day-old wild-type and Stat1
KO 129sv mice in direct comparison to the parental rSA11 at 1  107 PFU. The overall
trends of diarrheal development between rSA11 and rSA11-NSP1-null in wild-type
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FIG 8 Viral loads of rD6/2-2g and rD6/2-2g-NSP1-null in the small intestines and indicated extraintestinal
tissues in Stat1 KO 129sv mice. (A) Five-day-old Stat1 KO 129sv pups were orally infected with 1.5  103 FFU of
rD6/2-2g and rD6/2-2g-NSP1-null. The duodenum, jejunum, and ileum were collected at 2 dpi, and RV NSP5
mRNA levels were detected by RT-qPCR. (B to E) Same as panel A except that blood, MLNs, bile duct, and liver
were collected instead. *, P , 0.05; **, P , 0.01; ***, P , 0.001; n.s., not signiﬁcant (Mann-Whitney U test for
panel A and unpaired Student’s t test for panels B to E).
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DISCUSSION
In this study, we exploited a recently developed and further optimized plasmidbased RG system to examine the role of NSP1 in RV replication in vivo. Previous studies
showed that naturally isolated RV SA11-5S and SA11-30-1A variants (26), and some RGrescued recombinant RVs, albeit unable to induce IRF3 degradation, replicate efﬁciently in cell culture (20). However, because of the limited replication and transmission
of nonmurine heterologous RVs in mice (27), until now it has been difﬁcult to assess
whether NSP1 is required for RV replication in vivo. Here, taking advantage of an optimized RG system, we rescued an NSP1-deﬁcient murine virus-like rD6/2-2g-NSP1-null
virus (Fig. 1), which replicated similarly to rD6/2-2g in MA104 cells (Fig. 2A and B). The
plaques formed by rD6/2-2g-NSP1-null were, however, much smaller than those of
rD6/2-2g (Fig. 2C), reminiscent of the data derived from the SA11 strain (19, 20). The
smaller plaque size may reﬂect a defect in the efﬁciency of cell-cell spread.
The similar growth properties of rD6/2-2g-NSP1-null and rD6/2-2g in MA104 cells
may be due to IFN-defective MA104 cells, which also supported comparable propagation of the parental rSA11 strain and recombinant rSA11-dC103 and rSA11-Nluc that
both lack an intact NSP1 expression. The replication of rSA11-Nluc in IFN-competent
cells was, however, much lower than that of rSA11 (19, 28), and this phenotype may be
caused by the missing IRF3 degradation ability of rSA11-dC103 and rSA11-Nluc. Thus,
in order to assess whether NSP1 was important to murine RV replication in IFN-competent cells, we examined the growth curves of rD6/2-2g-NSP1-null and rD6/2-2g in
HEK293 and HAP1 cells. Intriguingly, these two viruses still exhibited similar replication
properties (Fig. 3). Although we observed a 3- to 4-fold-higher titer of rD6/2-2g in
HAP1 cells at 48 hpi, there were no statistically signiﬁcant differences at any other time
points (Fig. 3). These results raise the possibilities that another RV protein may compensate for the loss of NSP1 or that the IFN-mediated antiviral activities are both cell
type and virus strain speciﬁc.
Recent studies have reported that the recombinant murine-like RV (rD6/2-2g) replicates robustly in the small intestines of 129sv suckling pups, that rD6/2-2g infection
causes diarrheal diseases, and that the transmission efﬁciency of rD6/2-2g is similar to
that of the original reassortant murine RV D6/2 strain (22). Here, we orally inoculated
the 129sv mice with rD6/2-2g or rD6/2-2g-NSP1-null. The lower percentage of diarrheal
disease and lower titer of RV shedding in rD6/2-2g-NSP1-null-infected pups at the early
time points revealed that NSP1 protein is important for virus pathogenesis in vivo.
However, starting on 3 dpi, the curves of diarrhea and virus shedding of rD6/2-2gNSP1-null approached those of the rD6/2-2g parental strain. This observation led us to
ask whether the rD6/2-2g-NSP1-null reverted to wild-type rD6/2-2g, despite the presence of two stop codons inserted at the very beginning of the NSP1 open reading
frame. To our surprise, all of the gene 5 segments ampliﬁed from rD6/2-2g-NSP1null-infected 129sv mice examined at 4 dpi had completely reverted to wild-type
sequences (see Fig. S3B in the supplemental material). We performed the infection
experiments with rD6/2-2g and rD6/2-2g-NSP1-null at different time points, and these
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129sv mice were similar (Fig. S5A). In Stat1 KO mice, both viruses developed less diarrhea than in the wild-type animals but the rSA11-NSP1-null seemed to be even more
attenuated than rSA11 (Fig. S5A). We also quantiﬁed RV antigen shedding in the stool
samples collected from rSA11- or rSA11-NSP1-null-infected mice by an enzyme-linked
immunosorbent assay (ELISA). While neither virus had detectable shedding in wildtype pups, we observed that rSA11 but not rSA11-NSP1-null resulted in transient shedding between 4 and 6 dpi (Fig. S5B). Consistently, we found higher viral loads in the
small intestines upon rSA11 infection than upon rSA11-NSP1-null infection of Stat1 KO
mice (Fig. S5C). Taken together, these data suggest that despite limited replication
ability, the heterologous simian RV SA11 strain is also attenuated without NSP1 expression in IFN-deﬁcient animals, resembling what we observed with homologous murine
RV infections.

data were repeated in two independent experiments (Fig. S2); thus, the reversion
observed in rD6/2-2g-NSP1-null-inoculated mice is unlikely to be due to the contamination by rD6/2-2g. We also ampliﬁed NSP1 from fecal specimens obtained on days 1
to 4 postinfection from Stat1 KO 129sv mice. Two out of 8 mice had complete NSP1 reversion mutations, and the remaining 6 had incomplete reversion as early as 1 dpi;
meanwhile, all the 8 Stat1 KO 129sv mice had complete NSP1 reversion mutations at
4 dpi (Fig. S3C). These results emphasized the essential role of NSP1 protein during RV
replication in vivo. We found signiﬁcantly higher levels of rD6/2-2g in the small intestines, blood, MLNs, bile duct, and liver compared with rD6/2-2g-NSP1-null-infected
Stat1 KO 129sv mice at 2 dpi (Fig. 8), although the only statistically signiﬁcant differences examined in the wild-type 129sv mice at 2 dpi were in the ileum and MLNs (Fig. 5).
We found that the replication of rD6/2-2g in small intestines and systemic organs in
Stat1 KO 129sv mice was about 10-fold higher than in wild-type 129sv mice, but the
replication of rD6/2-2g-NSP1-null in these tissues in wild-type 129sv mice was similar
to that of Stat1 KO 129sv mice (Fig. 5 and 8). These data suggest that NSP1 protein
contributes to virus replication but that this contribution appears to be independent
of IFN signaling during RV infection in vivo. We also found that the replication levels of
the heterologous rSA11-NSP1-null and rSA11 simian RVs were comparable in wild-type
129sv mice, but the replication of rSA11 was increased in Stat1 KO 129sv mice (Fig. S5).
Unlike rD6/2-2g, we did not see a recovery of rSA11-NSP1-null in wild-type mice, probably because the replication level was too low to permit generation and selection of
sufﬁcient mutations by the viral polymerase.
Although this study identiﬁes an essential role of the NSP1 protein in promoting RV
replication in vivo, the precise mechanisms of this promoting phenotype remain to be
further explored. Our data suggest that NSP1 likely facilitates virus replication independently of the IFN and inﬂammasome signaling and beyond one replication cycle.
Interestingly, NSP1 has been shown to be localized to the nucleus during viral infection, and this relocalization disrupted the function of promyelocytic nuclear bodies,
which was related to host stress responses (29). More recently, NSP1 has been linked
to the inhibition of the transcription (30) but not the translation (14) of IRF1. It will be
of interest to determine whether the NSP1-IRF1 signaling pathway is involved in RV
replication in vivo. In several ways, RV NSP1 resembles inﬂuenza virus NS1, another
multifunctional protein that potentially targets protein kinase R (31) and autophagy
(32). In this sense, several other arms of the innate immune signaling remain to be
examined. Meanwhile, it is also plausible that NSP1 contributes to RV infection in ways
other than the innate immune antagonism. For instance, NSP1 associates with viral
RNA (33) and may facilitate viral assembly or egress beyond the replication step.
In future studies, it will also be interesting to investigate the exact domains of NSP1
responsible for its proviral replication functions in vivo. In light of the perplexing ﬁnding that the replication of NSP1-null RV is not rescued in Stat1 KO mice, deletion of the
IRF3 binding site in murine RV NSP1 or swapping that with the b -TrCP recognition motif
could be revealing. In addition, since NSP1 is involved in RV host range restriction, one
can study the NSP1 functionality in the context of a homologous virus infection by
replacing the murine RV NSP1 with NSP1s derived from heterologous RV strains. With an
optimized RG system and fully virulent murine RVs, we expect to uncover the physiological functions of other RV-encoded viral factors. Finally, while our studies here show that
NSP1 is pivotal for rotavirus replication in vivo and represents a logical viral target for
replication restriction-based attenuation, site-directed mutagenesis may not be the optimal approach to disrupt NSP1 expression due to the quick and complete reversion.
Moving forward, we plan to generate recombinant RVs that lack the complete or a portion of the NSP1 coding region to prevent the reversion to virulent parental strains. We
will be able to test the replication, pathogenesis, and immunogenicity of the new NSP1truncated RVs as novel vaccine candidates against subsequent RV infections in small animal models. We anticipate that a deeper understanding of the RV-host interactions and
RV pathogenesis in vivo will guide the development of novel next-generation RV vaccine
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candidates with improved efﬁcacy in developing countries and higher compatibility with
an immunocompromised population.

Cells and viruses. The rhesus monkey kidney epithelial MA104 cells were grown in medium 199
(Gibco) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (VWR), 100 U/ml penicillin,
100 m g/ml streptomycin, and 0.292 mg/ml L-glutamine. The BHK-T7 cell line, a baby hamster kidney cell
line stably expressing T7 RNA polymerase, was kindly gifted by Ursula Buchholz (Laboratory of Infectious
Diseases, NIAID, NIH, USA) and was cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Gibco)
supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 m g/ml streptomycin, and
0.292 mg/ml L-glutamine, and also 0.3 mg/ml G418 (Promega) was added to the culture medium at every other passage. MA104 cells stably expressing parainﬂuenza virus 5 V protein and bovine viral diarrhea virus N protease were cultured in medium 199 supplemented with 10% heat-inactivated FBS, 100
U/ml penicillin, 100 m g/ml streptomycin, 0.292 mg/ml L-glutamine. Blasticidin (10 m g/ml) and puromycin
(10 m g/ml) were added to the medium at every other passage as described previously (22).
The simian RV SA11 strain and the murine RV D6/2 strain were propagated as described previously
(7, 19). Brieﬂy, RV stock was activated with 5 m g/ml trypsin (Gibco Life Technologies, Carlsbad, CA) for
20 min at 37°C. The activated RVs were incubated with MA104 cells, which were washed twice with serum-free medium 199 for 1 h at 37°C. Then, the viruses were removed and the new serum-free medium
199 supplemented with 0.5 m g/ml trypsin was added to the MA104 cells. Virus titers were determined
by a standard plaque assay in MA104 cells.
Sequencing of the murine RV D6/2 strain. Viral particle enrichment of cell culture supernatant was
performed based on the NetoVIR protocol (34). Brieﬂy, cell culture supernatant was centrifuged for 3 min at
17,000  g and ﬁltered with a 0.8-m m polyethersulfone (PES) ﬁlter (Sartorius). The ﬁltrate was treated with
Benzonase (Novagen) and micrococcal nuclease (New England BioLabs) at 37°C for 2 h to remove the freeﬂoating nucleic acids. Subsequently, samples were extracted using the QIAamp viral RNA minikit (Qiagen)
according to the manufacturer's instructions, without addition of carrier RNA to the lysis buffer. Reverse
transcription and second-strand synthesis were performed by an adjusted version of the whole-transcriptome ampliﬁcation (WTA2) protocol (Sigma-Aldrich), as described previously (35). A sequencing library was
constructed with the Nextera XT library preparation kit (Illumina). The size of the library was checked with
Bioanalyzer (Agilent Technologies) with a high-sensitivity DNA chip, and the 2 nM pooled libraries were
sequenced on an Illumina NextSeq 500 platform (2  150-bp paired ends).
Low-quality reads, ambiguous bases, and primer and adaptor sequences were removed from the
paired-end reads with Trimmomatic with default parameters (36). Trimmed reads were de novo assembled
with metaSPAdes from SPAdes software using 21, 33, 55, and 77 k-mer lengths (37). The obtained contigs
were annotated with DIAMOND against a nonredundant protein database (38). Contigs annotated as “rotavirus” were extracted. The obtained sequences were veriﬁed in silico by remapping the trimmed reads to
the obtained contigs using BWA software (39).
Construction of a T7 plasmid carrying mutant gene 5 of D6/2 or SA11. To rescue an NSP1-deﬁcient murine-like RV, we generated a pT7-D6/2-NSP1-null virus via the QuikChange II site-directed mutagenesis kit (Agilent Technology) based on pT7-D6/2-NSP1 (22). Brieﬂy, the AAG and TGC codons in the
NSP1 open reading frame (ORF) of D6/2 were replaced with stop codons TAG and TGA at nucleotide
position 43 to 45 and 52 to 55 in pT7-D6/2-NSP1. The mutant primers used were rD6/2-2g-NSP1-null
forward primer, 59-GTGTTAGCCATGGCGGCCTTTTAGGACGCGTGATTCCATTACAGAAGG-39, and rD6/22g-NSP1-null reverse primer, 59-CCTTCTGTAATGGAATCACGCGTCCTAAAAGGCCGCCATGGCTAACAC39. To rescue the NSP1-deﬁcient simian RV SA11, we generated the plasmid pT7-SA11-NSP1-null using
the same strategies described above. The mutant primers used were SA11-NSP1-null forward primer,
59-GCTACTTTTAAAGATGCATGCTTTTAATAGCGTAGATTAACTGCTTTAAATCGG-39, and SA11-NSP1-null
reverse primer, 59-CCGATTTAAAGCAGTTAATCTACGCTATTAAAAGCATGCATCTTTAAAAGTAGC-39.
Generation of recombinant murine-virus-like and simian RVs. Recombinant rD6/2-2g and rD6/22g-NSP1-null were generated according to the optimized entirely plasmid-based RG system described
recently (22). Brieﬂy, 0.4 m g of pT7-SA11-VP1, pT7-D6/2-VP2, pT7-D6/2-VP3, pT7-D6/2-VP4, pT7-D6/2VP6, pT7-D6/2-VP7, pT7-D6/2-NSP1 (or pT7-rD6/2-NSP1-null), pT7-D6/2-NSP3, and pT7-SA11-NSP4;
1.2 m g of pT7-D6/2-NSP2 and pT7-D6/2-NSP5; 0.8 m g of the helper plasmid C3P3-G1; and 14 m l TransITLT1 (Mirus) transfection reagent were mixed together and transfected into BHK-T7 cells in a 12-well
plate. Eighteen hours later, the transfected BHK-T7 cells were washed twice with FBS-free DMEM and
then supplemented with 800 m l fresh FBS-free DMEM, and 24 h later, 1  105 MA104 N*V cells in 200 m l
FBS-free DMEM along with 0.5 m g/ml trypsin were added to the transfected BHK-T7 cells for another
3 days. After that, mixed cells were frozen and thawed 3 times. The rescued virus was propagated for
two passages in MA104 cells in a 6-well plate, and then the virus was propagated in a T75 ﬂask to produce the virus stock.
The recombinant SA11 and SA11-NSP1-null were rescued using the same protocol described above,
expect that the plasmids used were pT7-SA11-VP1, pT7-SA11-VP2, pT7-SA11-VP3, pT7-SA11-VP4, pT7SA11-VP6, pT7-SA11-VP7, pT7-SA11-NSP1 (or pT7-SA11-NSP1-null), pT7-SA11-NSP2, pT7-SA11-NSP3,
pT7-SA11-NSP4, and pT-SA11-NSP5.
Puriﬁcation of RV particles by sucrose gradient centrifugation. RVs were concentrated by sucrose
cushion as described previously (40). Brieﬂy, RVs propagated in T75 ﬂasks were harvested by repeating
the freeze-thaw cycle three times. Then, we clariﬁed the crude lysate of cell debris by centrifugation at
3,000  g for 1 h at 4°C. After that, 8 ml of clariﬁed RVs was placed into a 10-ml SW44 ultracentrifuge
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tube, and 2 ml 40% (wt/vol) sucrose was carefully added to the bottom of the ultracentrifuge tube and
subjected to centrifugation at 35,000 rpm for 3 h at 4°C. At last, we removed the supernatant and added
200 m l FBS-free medium 199 to resuspend the concentrated RVs at 4°C overnight.
Electrophoretic analysis of viral genomic dsRNAs. Viral genomic dsRNAs were extracted from sucrose cushion-concentrated viruses using TRIzol reagent (Thermo Scientiﬁc) according to the manufacturer’s protocol (41). Then, the dsRNAs were mixed with gel loading dye, purple (6) (New England
Biolabs). Samples were loaded into a 4 to 15% precast polyacrylamide gel and run for 3 h at 180 V. The
gel was stained for 1 h with 0.1 m g/ml ethidium bromide and visualized by the ChemiDoc MP imaging
system (Bio-Rad).
Restriction enzyme digestion and sequencing analysis. The total RNA of the recombinant rD6/22g and rD6/2-2g-NSP1-null virus stocks and stool samples was extracted by TRIzol. Total RNA was
reverse transcribed to cDNA using a high-capacity cDNA reverse transcription kit with RNase inhibitor
(Applied Biosystems) according to the user guide. Brieﬂy, 0.8 m g of RNA, 2 m l of 10 reverse transcription (RT) buffer, 0.8 m l of 100 mM deoxynucleoside triphosphate (dNTP) mix, 2 m l of RT random primers,
0.1 m l of RNase inhibitor, 0.1 m l of MultiScribe reverse transcriptase, and a ﬂexible amount of nucleasefree H2O were added to the 20-m l reaction mixture. The reverse transcription thermocycling program
was set at 25°C for 10 min, 37°C for 2 h, and 85°C for 5 min.
NSP1 59-end fragments were ampliﬁed by Phusion Hot Start II DNA polymerase (Thermo
Scientiﬁc) following the manufacturer’s guide. The primers used for PCR were NSP1 forward primer,
59-GTCTTGTGTTAGCCATGGC-39, and NSP1 reverse primer, 59-CAGCGGTTAAAGTGATCGG-39. PCR products were gel puriﬁed using the QIAquick gel extraction kit (Qiagen). NSP1 fragments of 0.1 m g were
digested by restriction enzyme HinfI (New England Biolabs [NEB]) for 1 h at 37°C. The enzyme-digested
products were separated by 2% agarose gel electrophoresis, stained by ethidium bromide, and visualized
by the ChemiDoc MP imaging system (Bio-Rad). A separate set of puriﬁed NSP1 fragments were sent for
Sanger sequencing.
Immunoblotting. MA104 cells in a 24-well plate were infected by rD6/2-2g or rD6/2-2g-NSP1-null at
an MOI of 3 for 6 h. Then, uninfected and infected MA104 cells were washed twice with ice-cold phosphate-buffered saline (PBS; Thermo Scientiﬁc) and lysed in RIPA buffer (150 mM NaCl, 1.0% IGEPAL CA630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0; Sigma-Aldrich) supplemented with 1
protease inhibitor cocktail (Thermo Scientiﬁc) for 30 min at 4°C. After that, cell debris was removed by
centrifugation at 12,000  g for 10 min at 4°C. Samples were resolved in precast SDS-PAGE gels (4 to
15%; Bio-Rad) and transferred to a nitrocellulose membrane (0.45 m m; Bio-Rad). The membrane was
incubated with blocking buffer (5% bovine serum albumin [BSA] diluted in PBS supplemented with 0.1%
Tween 20) for 1 h at room temperature. Then, the membrane was incubated with anti-IRF3 rabbit monoclonal antibody (CST; catalog no. 4302; 1:1,000), anti-RV VP6 mouse monoclonal antibody (Santa Cruz
Biotechnology; sc-101363; 1:1,000), and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) rabbit monoclonal antibody (CST; catalog no. 2118; 1:1,000), followed by incubation with anti-mouse IgG
(CST; catalog no. 7076; 1:5,000) or anti-rabbit IgG (CST; catalog no. 7074; 1:5,000) horseradish peroxidase
(HRP)-linked antibodies. The antigen-antibody complex was detected using Clarity Western ECL substrate (Bio-Rad) and the ChemiDoc MP imaging system according to the manufacturer’s manuals.
RT-qPCR. RT-qPCR was performed using the above cDNA as described previously (23). The expression
level of housekeeping gene GAPDH was quantiﬁed by 2 SYBR green master mix (Applied Biosystems),
and NSP5 was measured by 2 TaqMan Fast Advanced master mix (Applied Biosystems). The primers
used in this study were as follows: human GAPDH forward primer, 59-GGAGCGAGATCCCTCCAAAAT-39,
and reverse primer, 59-GGCTGTTGTCATACTTCTCATGG-39; mouse GAPDH forward primer, 59TCTGGAAAGCTGTGCCGTG-39, and reverse primer, 59-CCAGTGAGCTTCCCGTTCAG-39; and NSP5 forward primer, 59-CTGCTTCAAACGATCCACTCAC-39, reverse primer, 59-TGAATCCATAGACACGCC-39,
and probe, 59-CY5/TCAAATGCAGTTAAGACAAATGCAGACGCT/IABRQSP-39. For the viral load measurement in the small intestinal segments and systemic organs, GAPDH levels were quantiﬁed and used
to normalize the different cell numbers in the tissues harvested. The y axis stands for the percentage
of NSP5 mRNA levels relative to GAPDH levels, plotted on a log10 scale.
Plaque assay. The plaque assay was performed as described previously (42). Brieﬂy, 1  105 MA104
cells/ml were seeded in a 6-well plate, and virus samples were serially diluted 10-fold and incubated
with the conﬂuent MA104 cells for 1 h at 37°C. Then, samples were replaced by FBS-free medium 199
with 0.1% agarose supplemented with 0.5 m g/ml trypsin and put back to 37°C. Plaques were visualized
at day 3 to day 5 postinoculation by 0.0165% neutral red staining. In order to measure the size of the
plaques, we recorded more than 75 plaques with the microscope (Echo) in two different experiments.
Then, the diameters of the plaques were calculated with the annotation tool of the microscope.
Focus-forming unit assay. The focus-forming assay was conducted as described previously (41).
Brieﬂy, 1  105 MA104 cells/ml were seeded in a 96-well plate, and then virus samples were serially
diluted 5- or 10-fold and incubated with a monolayer of MA104 cells for 10 h or overnight at 37°C. Then,
cells were ﬁxed with 10% formalin, followed by permeabilization with 1% Tween 20. After that, cells
were incubated with anti-rotavirus capsid mouse monoclonal antibody and anti-mouse HRP-linked antibodies. The foci were stained by 3-amino-9-ethylcarbazole HRP substrate (Vector Laboratories) and
stopped by washing twice with PBS.
Virus competition assay. The virus competition assay was conducted as described previously (43).
Brieﬂy, fully conﬂuent MA104 cells were infected by rD6/2-2g and rD6/2-2g-NSP1-null at an MOI of 0.01
or 3 for 1, 8, and 24 h at 37°C. The total RNA was extracted from the infected MA104 cells, and the 59end fragments of NSP1 were ampliﬁed as described above. The ampliﬁed fragments were gel extracted
and analyzed by Sanger sequencing.
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Mouse infection. Wild-type 129S1/SvImJ, Stat1 KO, wild-type C57BL/6, and Asc KO mice were purchased from the Jackson Laboratory and Taconic Biosciences and bred locally at the Washington
University in St. Louis (WUSTL) BJC Institute of Health (BJCIH) vivarium. Five-day-old suckling pups were
orally infected with rescued rD6/2-2g (1.5  103 FFU) and rD6/2-2g-NSP1-null (1.5  103 FFU) (44).
Diarrhea was evaluated from day 1 to day 12 postinfection. In the meantime, feces from infected mice
were also collected, and the focus-forming assay was used to titrate RV in stool samples. Brieﬂy, 50 m l
PBS with calcium and magnesium was added to the 1.5-ml Eppendorf tubes, and the weight was
recorded. After we collected the feces, these tubes were weighed again, and the stool samples were homogenized before we made the serial dilution to conduct the focus-forming assay. Duodenum, jejunum,
ileum, blood, mesenteric lymph node, and liver were collected from inoculated pups at day 2 postinfection, immediately placed in liquid nitrogen, and stored at 280°C until use. RNA was extracted from those
tissues using the RNeasy Plus minikit (Qiagen) according to the manufacturer’s protocol. RT-qPCR was
used to measure RV NSP5 expression levels, and FFU assays were used to quantify the amount of infectious virus in the stool samples as described previously (45).
Statistical analysis. Bar graphs in Fig. 2A to C and Fig. 3A and B were displayed as means 6 standard deviations (SD). Bar graphs in Fig. 4B, Fig. 5A to E, Fig. 6A to C, Fig. 7B, Fig. 8A to E, and Fig. S2, S4,
and S5B and C in the supplemental material were displayed as means 6 standard errors of means (SEM).
Statistical signiﬁcance in Fig. 2A to C, Fig. 3A and B, Fig. 5B to E, Fig. 8B to E, and Fig. S5C was analyzed
by unpaired Student’s t test using GraphPad Prism 9.1.1. Statistical signiﬁcance in Fig. 4B, Fig. 7B, and
Fig. S2 and S5B was calculated by two-way analysis of variance (ANOVA). Statistical signiﬁcance in
Fig. 5A, Fig. 6A to C, Fig. 8A, and Fig. S4A and B was analyzed by Mann-Whitney U test (*, P , 0.05; **,
P , 0.01; ***, P , 0.001; n.s., not signiﬁcant).
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